Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation

Obstetrics and Gynecology

Volumn 88, Issue 2, 1996, Pages 274-279

  Lin, Ho Hsiung ^a   Cheng, Wen Fang ^a   Chan, Kin Wei A ^a   Chang, Daw Yuan ^a   Chen, Chun Kai ^a   Huang, Su Cheng ^a,b  

^a Graduate Institute of Epidemiology and Preventive Medicine   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER;

EID: 0030221623     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00145-7     Document Type: Article

References (27)

1. 1. Morgan LS, Nelson JH Jr. Surgical treatment of early cervical cancer. Semin Oncol 1982;9:312-30.
2. 2. Gauthier P, Gore I, Shingleton HM, Soong SJ, Orr JW Jr, Hatch KD. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 1985;66:569-74.
3. 3. Fuller AF Jr, Elliot N, Kosloff C, Lewis JL Jr. Lymph node metastases form carcinoma of the cervix, stage IB and IIA: Implication for prognosis and treatment. Gynecol Oncol 1982;13:165-74.
4. 4. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980;138: 550-6.
5. 5. Hogan WM, Littman P, Griner L, Miller CL, Mikuta JJ. Results of radiation therapy given after radical hysterectomy. Cancer 1982; 49:1278-85.
6. 6. Ballon SC, Berman ML, Lagasse LD, Petrilli ES, Castaldo TW. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 1981;57:90-5.
7. 7. Russell AH, Tong DY, Figge DC, Tamimi HK, Greer BE, Elder SJ. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: Pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomy. Int J Radiat Oncol 1984;10:211-4.
8. 8. Inoue T, Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation. Cancer 1984;54:1714-9.
9. 9. Larson DM, Stringer CA, Copeland LJ, Gershenson DM, Malone JM Jr, Rutledge FN. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy. Obstet Gynecol 1987;69:378-81.
10. 10. Kim RY, Salter MM, Shingleton HM. Adjuvant postoperative radiation therapy following radical hysterectomy in stage IB CA of the cervix-analysis of treatment failure. Int J Radiat Oncol Biol Phys 1988;14:445-9.
11. 11. Rettenmaier MA, Casanova DM, Micha JP, Moran MF, Ramsanghani NS, Syed NA, et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage IB cervical cancer. Cancer 1989;63:2220-3.
12. 12. Remy JC, Maio TD, Fruchter RG, Sedlis A, Boyce JG, Sohn CK, et al. Adjunctive radiation after radical hysterectomy in stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 1990;38: 161-5.
13. 13. Weiner SA, Aristizabal S, Alberts DS, Surwit EA, Deatherage-Deuser K. A phase II trial of mitomycin, vincristine, bleomycin and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecol Oncol 1988;30:1-6.
14. 14. Kim DS, Moon H, Hwang YY, Cho SH. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 1988;29:321-32.
15. 15. Kim DS, Moon H, Kim KT, Hwang YY, Cho SH, Kim SR. Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor. Gynecol Oncol 1989;33:225-30.
16. 16. Panici PB, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 1991;67:372-9.
17. 17. Kuehnle H, Meerpohl HG, Eiermann W, Achterrath W. Neoadjuvant therapy for cervical cancer. Semin Oncol 1992;19:94-8.
18. 18. Sardi JS, Sananes C, Giaroli A, Bayo J, Rutda NG, Vighi S, et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993;49:156-65.
19. 19. Lai CH, Lin TS, Soong YK, Chen HF. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989; 35:193-8.
20. 20. Killackey MA, Boardman L, Carroll DS. Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer. Gynecol Oncol 1993;49:377-9.
21. 21. Carlson JA Jr. Chemotherapy of cervical cancer. Clin Obstet Gynecol 1990;33:910-6.
22. 22. Ferenczy A, Winkler B. Carcinoma and metastatic tumors of the cervix. In Kurman RJ, ed. Blaustein's pathology of the female genital tract. 3rd ed. New York: Springer-Verlag, 1987:237-40.
23. 23. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989;32:292-6.
24. 24. Jacob AJ, Perez CA, Camel HM, Kao MS. Complications in patients receiving both irradiation and radical hysterectomy for carcinoma of the uterine cervix. Gynecol Oncol 1985;22:273-80.
25. 25. Sheets EE, Berman ML, Hrountas CK, Liao SY, DiSaia PJ. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 1988;71:10-4.
26. 26. O'Hanlan KA, Goldberg GL, Jones JG, Runowicz CD, Ehrlich L, Rodriguez-Rodriguez L. Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: Review of the literature. Gynecol Oncol 1991;43:167-72.
27. 27. Abeler VM, Holm R, Nesland JM, Kjorstad KE. Small cell carcinoma of the cervix: A clinicopathologic study of 26 patients. Cancer 1994;73:672-7.